Medicinal Product Shortages - update - 9 August 2023

Notice type: Advisory

Date: 09/08/2023

This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.

Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

 

Resolved shortages

The following shortages have been resolved and supply has resumed to the Irish market:

Product

Active Ingredient(s)

Atecor 25mg Tablets

 

PA0711/003/001

 

Rowex Ltd

Atenolol

Colofac 135 mg Tablets

 

PA2010/007/001

 

Mylan IRE Healthcare Limited

Mebeverine

Gabapentin Aurobindo 100mg

Capsules

 

PA1445/025/001

 

Aurobindo Pharma (Malta) Limited

Gabapentin

Eligard 45mg powder and solvent for solution for injection

 

PA0812/005/003

 

Recordati Industria Chimica e Farmaceutica SpA

Leuprorelin

Gabapentin Aurobindo 300mg

Capsules

 

PA1445/025/002

 

Aurobindo Pharma (Malta) Limited

Gabapentin

Imvaggis 0.03 mg Pessary

 

PA1054/005/001

 

Laboratoires Besins International

Estriol

Novorapid 100 units/ml Solution for Injection

 

Vial presentation

 

EU/1/99/119/001

 

Novo Nordisk A/S

Insulin Aspart

Olmesartan Rowex 20mg Film-Coated Tablets

 

PA0711/255/002

 

Rowex Ltd

Olmesartan

 

 

 

Newly notified shortages

The HPRA has been notified of a shortage of the following products:

Product

Active Ingredient(s)

Canesten Thrush Cream 2%

 

PA1410/039/012

 

Bayer Limited

Clotrimazole

Derbac M Liquid 0.5% w/w cutaneous emulsion

 

PA22702/001/001

 

LanesHealth (Ireland) Limited

Malathion

Erythrocin 250 mg Tablets

 

PA1142/008/002

 

Amdipharm Limited

Erythromycin

Mirap 30 mg Film-Coated Tablets

 

PA0711/062/002

 

Rowex Ltd

Mirtazapine

Neo-Cytamen 1000 micrograms/ml Solution for Injection

 

PA1638/004/001

 

RPH Pharmaceuticals AB

Hydroxocobalamin

Rasagiline Bluefish 1mg tablets

 

PA1436/028/001

 

Bluefish Pharmaceuticals AB

Rasagiline

Rasagiline Clonmel 1mg tablets

 

PA0126/276/001

 

Clonmel Healthcare Ltd

Rasagiline

Rasagiline Rowex 1mg tablets

 

PA0711/264/001

 

Rowex Ltd.

Rasagiline

Rosuvastatin Rowa 10 mg film-coated tablets

 

PA0074/093/002

 

Rowa Pharmaceuticals Limited

Rosuvastatin

Sunitinib Rowex 12.5 mg hard capsules

 

PA0711/289/001

 

Rowex Ltd

Sunitinib

 

Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.



« Back